Skip to content

Longevity

Humanin

Also called HN, HNG

InjectableEvidence C3x per week
Half-life
0.5hours
Typical vial
5 / 10mg
Research amounts
5–10mg

per administration

Common schedule
3x per week
Animal or lab only

Only animal or lab studies exist — no human study has set an amount.

Work out your draw

These numbers are a starting point — change any of them.

3 mL cartridge · 300 units loaded300units dialled
Concentration
1.67mg/mL
Volume per draw
3mL
Units to dial
300
Doses per cartridge
1

This is 300 units, past the 60-unit dial. Splitting it across administrations, or using less water to raise the concentration, brings it back into range.

Dial range varies by pen; 1–60 units is the common configuration.

Vial label

Copy this into your label printer.

Published research contexts for Humanin describe 510 mg per administration. Descriptive only, not a recommendation.

Mitochondrial-derived peptide; human pharmacokinetic data is thin.

A mitochondrial-derived peptide, with HNG a more stable analog; evidence is preclinical and circulating amounts are community-derived rather than trial-established, so no schedule table is shown.

Modelled level — 3x per week

1× is the peak after a single dose.

Steady-state peak
1.00× single dose

Read off the modelled curve, not an even-interval formula

Time to steady state
3hours

About five half-lives

Administrations
3/ week

Where these numbers come from

  • Humanin mitochondrial-derived peptide literatureLargely rodent and cell-model work on cytoprotection and metabolism; human dosing is not established.

Next steps